Functional connections with deep brain stimulation (DBS) sites that are... | Download Scientific Diagram
Journal of Movement Disorders
Personalised medicine and genomics against Parkinson's disease
![Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1353802020308610-gr1.jpg "Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging - ScienceDirect")
Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging - ScienceDirect
Can low-intensity tACS genuinely entrain neural activity in vivo? - Brain Stimulation: Basic, Translational, and Clinical Research in Neuromodulation
![Imaging histamine H3 receptors with [18F]FMH3: Test–retest and occupancy studies in the non‐human primate - Sandiego - 2019 - Synapse - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/7c4eb71a-de1c-45f2-8a6f-e88b3038350b/syn22096-toc-0001-m.jpg "Imaging histamine H3 receptors with [18F]FMH3: Test–retest and occupancy studies in the non‐human primate - Sandiego - 2019 - Synapse - Wiley Online Library")
Imaging histamine H3 receptors with [18F]FMH3: Test–retest and occupancy studies in the non‐human primate - Sandiego - 2019 - Synapse - Wiley Online Library
Lesiones en la sustancia blanca en el paciente anciano. Utilización de la terminología adecuada - ScienceDirect
Parkinson disease | Radiology Reference Article | Radiopaedia.org
La enfermedad de Parkinson: diagnóstico y avances en el conocimiento de la etiología y en el tratamiento | Medicina Integral
Frontiers | Transcranial Alternating Current Stimulation: A Potential Modulator for Pathological Oscillations in Parkinson's Disease?
![Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2213158218301694-gr1.jpg "Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET - ScienceDirect")
Investigation of serotonergic Parkinson's disease-related covariance pattern using [11C]-DASB/PET - ScienceDirect
evidence based medicine – Kamal R. Mahtani
TSPO imaging in parkinsonian disorders. - Abstract - Europe PMC
Neurodegenerative Diseases: Parkinson Disease | SpringerLink
Una sola conmoción cerebral puede aumentar el riesgo de la enfermedad de Parkinson - El médico interactivo
TC CRANEAL, PARKINSON - Ciclo Imagen para el Diagnóstico y Medicina Nuclear
PDF) The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson's Disease
-PK11195 PET in idiopathic Parkinson's disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969996105002263-gr1.jpg "In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease - ScienceDirect")
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease - ScienceDirect
![PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.1c00651/asset/images/large/cn1c00651_0008.jpeg "PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ | ACS Chemical Neuroscience")
PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ | ACS Chemical Neuroscience
Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging
Diagnóstico Parkinson
NEUROIMÁGENES EN ENFERMEDAD DE PARKINSON: ROL DE LA RESONANCIA MAGNÉTICA, EL SPECT Y EL PET | Revista Médica Clínica Las Condes
![Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment](https://www.frontiersin.org/files/MyHome%20Article%20Library/528772/528772_Thumb_400.jpg "Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment")
Frontiers | Usefulness of PET With [18F]LBT-999 for the Evaluation of Presynaptic Dopaminergic Neuronal Loss in a Clinical Environment
Pacientes con enfermedad de Parkinson avanzada con y sin congelación de la marcha. Análisis comparativo de lesiones vasculares en resonancia magnética cerebral | Neurología
Synaptic density and neuronal metabolic function measured by PET in the unilateral 6-OHDA rat model of Parkinson's disease | bioRxiv
